Document is current
Any future updates will be listed below
-
Authors
Xi, Yongkang
Mao, Jianming
Chen, Samuel J. https://orcid.org/0000-0001-8501-7175
Moghimianavval, Hossein
Lee, Young Jin https://orcid.org/0000-0002-1396-7355
Panda, Ayush https://orcid.org/0009-0005-3583-8668
Huang, Alexander J.
Zhou, Daniel H.
Xu, L. Andy
Fu, Kayla Y.
Adera, Solomon
Ferguson, Andrew L. https://orcid.org/0000-0002-8829-9726
Liu, Allen P. https://orcid.org/0000-0002-0309-7018
-
Funding
Funding for this research was provided by:
United States Department of Defense | United States Army | U.S. Army Research, Development and Engineering Command | Army Research Office (W911NF-23-1-0050)
United States Department of Defense | United States Army | U.S. Army Research, Development and Engineering Command | Army Research Office (W911NF-23-1-0084)
- License Information
-
More Information
Article History
Received: 22 September 2025
Accepted: 13 April 2026
First Online: 2 May 2026
Competing interests
: A.L.F. is a co-founder and consultant of Evozyne, Inc. and a co-author of US Patent Applications 16/887,710 and 17/642,582, US Provisional Patent Applications 62/853,919, 62/900,420, 63/314,898, 63/479,378, 63/521,617, and 63/669,836, and International Patent Applications PCT/US2020/035206, PCT/US2020/050466, PCT/US24/10805, PCT/US25/35833. The remaining authors declare no competing interests.
